In a recently completed 429-horse trial, researchers reinforced the effectiveness and safety profile of Equioxx (firocoxib), the first equine oral, nonsteroidal anti-inflammatory drug (NSAID) to be approved in more than 20 years.
"This research helps prove the benefits of Equioxx, and it also demonstrates the commitment to continued research for all Merial products," said Doug Carithers,
To continue reading this article, become a member of TheHorse.com.
It's FREE and you'll get full access to more than 20,000 articles, video, free reports & more.
